Comparison of responses to SF-36 Health Survey questions with one-week and four-week recall periods.

by Keller, S D, Bayliss, M S, Ware, J E, Hsu, M A, Damiano, A M, Goss, T F
Published 1997

Tofacitinib in psoriatic arthritis patients: skin signs and symptoms and health‐related quality of life from two randomized phase 3 studies

by Merola, J.F., Papp, K.A., Nash, P., Gratacós, J., Boehncke, W.H., Thaçi, D., Graham, D., Hsu, M‐A., Wang, C., Wu, J., Young, P.
Published in J Eur Acad Dermatol Venereol (2020)